Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Baynes Roy D. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/05/2023 4 Baynes Roy D. (Director) has filed a Form 4 on Natera, Inc.
Txns: Granted 2,750 shares @ $0
Granted 4,255 options to buy @ $48.66, valued at $207k
05/26/2023 4 Baynes Roy D. (Director) has filed a Form 4 on Natera, Inc.
Txns: Exercised 3,534 restricted stock units @ $0
05/19/2023 4 Baynes Roy D. (Director) has filed a Form 4 on Travere Therapeutics, Inc.
Txns: Granted 4,500 shares @ $0
Granted 13,500 options to buy @ $17.11, valued at $231k
04/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/18/2023 4 Baynes Roy D. (Director) has filed a Form 4 on Natera, Inc.
Txns: Granted 312 shares @ $40.01, valued at $12.5k
10/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/02/2022 4/A Baynes Roy D. (Director) has filed a Form 4 on Natera, Inc.
Txns: Granted 344 shares @ $0
07/12/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/12/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/11/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2020 4 Baynes Roy D. (Director) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns: Granted 8,000 shares @ $0
Granted 24,500 options to buy @ $10.54, valued at $258.2k
06/16/2020 4 Baynes Roy D. (Director) has filed a Form 4 on Natera, Inc.
Txns: Granted 2,856 restricted stock units @ $0
Granted 5,712 options to buy @ $40.93, valued at $233.8k
05/19/2020 4 Baynes Roy D. (Director) has filed a Form 4 on Retrophin, Inc.
Txns: Granted 3,000 shares @ $0
Granted 9,000 options to buy @ $15.43, valued at $138.9k
07/01/2019 4 Baynes Roy D. (Director) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns: Granted 4,000 shares @ $0
Granted 13,000 options to buy @ $20.25, valued at $263.3k
05/29/2019 4 Baynes Roy D. (Director) has filed a Form 4 on Natera, Inc.
Txns: Granted 22,000 options to buy @ $22.83, valued at $502.3k
05/10/2019 4 Baynes Roy D. (Director) has filed a Form 4 on Retrophin, Inc.
Txns: Granted 2,000 shares @ $0
Granted 8,000 options to buy @ $17.94, valued at $143.5k
09/18/2018 4 Baynes Roy D. (Director) has filed a Form 4 on Natera, Inc.
Txns: Granted 16,530 options to buy @ $24.42, valued at $403.7k
09/12/2018 4 Baynes Roy D. (Director) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns: Granted 16,500 options to buy @ $41.05, valued at $677.3k
09/12/2018 3 Baynes Roy D. (Director) has filed a Form 3 on Atara Biotherapeutics, Inc.
08/02/2018 3 Baynes Roy D. (Director) has filed a Form 3 on Natera, Inc.
05/11/2018 4 Baynes Roy D. (Director) has filed a Form 4 on Retrophin, Inc.
Txns: Granted 2,500 shares @ $0
Granted 10,000 options to buy @ $26.52, valued at $265.2k
05/18/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/26/2016 4 Baynes Roy D. (Director) has filed a Form 4 on Retrophin, Inc.
Txns: Granted 4,000 shares @ $0
Granted 16,000 options to buy @ $17.5, valued at $280k
07/26/2016 3 Baynes Roy D. (Director) has filed a Form 3 on Retrophin, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy